Cui et al. (2020) found that the upregulation of FTO in hepatoblastoma patients is correlated with poor clinical outcomes. However, Zhuang et al. (2019) suggested that low FTO expression is correlated with poor prognosis in endometrial cancer, lung cancer, rectum adenocarcinoma, and pancreatic cancer. This evidence concerns the gene FTO and lung carcinoma.